Jan Y. Verbakel

12.0k total citations · 4 hit papers
134 papers, 4.9k citations indexed

About

Jan Y. Verbakel is a scholar working on Epidemiology, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Jan Y. Verbakel has authored 134 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Epidemiology, 21 papers in Infectious Diseases and 19 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Jan Y. Verbakel's work include Antibiotic Use and Resistance (18 papers), Emergency and Acute Care Studies (16 papers) and Sepsis Diagnosis and Treatment (16 papers). Jan Y. Verbakel is often cited by papers focused on Antibiotic Use and Resistance (18 papers), Emergency and Acute Care Studies (16 papers) and Sepsis Diagnosis and Treatment (16 papers). Jan Y. Verbakel collaborates with scholars based in Belgium, United Kingdom and Netherlands. Jan Y. Verbakel's co-authors include Ben Van Calster, Ewout W. Steyerberg, Evangelia Christodoulou, Gary S. Collins, Jie Ma, Laure Wynants, Jan Verbeek, Monique J. Roobol, Andrew J. Vickers and Ann Van den Bruel and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Jan Y. Verbakel

126 papers receiving 4.8k citations

Hit Papers

A systematic review shows no performance benefit of machi... 2018 2026 2020 2023 2019 2018 2023 2022 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models
    2019 1.2k citations Evangelia Christodoulou, Ewout W. Steyerberg et al. profile →
  2. Reporting and Interpreting Decision Curve Analysis: A Guide for Investigators
    2018 723 citations Ben Van Calster, Laure Wynants et al. European Urology profile →
  3. Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK
    2023 381 citations Nathalie Conrad, Shivani Misra et al. profile →
  4. Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK
    2022 222 citations Nathalie Conrad, Geert Verbeke et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Y. Verbakel Belgium 28 1.0k 631 612 574 432 134 4.9k
Varda Shalev Israel 42 920 0.9× 941 1.5× 616 1.0× 627 1.1× 452 1.0× 215 6.4k
Catherine Quantin France 38 1.2k 1.1× 651 1.0× 780 1.3× 787 1.4× 471 1.1× 326 5.7k
Karimollah Hajian‐Tilaki Iran 30 869 0.8× 627 1.0× 410 0.7× 872 1.5× 322 0.7× 204 5.5k
Kym I E Snell United Kingdom 27 979 0.9× 1.1k 1.7× 588 1.0× 371 0.6× 847 2.0× 73 5.3k
Robert Wolff United Kingdom 27 1.1k 1.0× 1.0k 1.6× 876 1.4× 471 0.8× 499 1.2× 96 6.6k
Gareth Ambler United Kingdom 40 1.0k 1.0× 861 1.4× 569 0.9× 425 0.7× 950 2.2× 150 5.4k
Laure Wynants Belgium 26 559 0.5× 671 1.1× 463 0.8× 417 0.7× 313 0.7× 72 3.6k
Joris A. H. de Groot Netherlands 25 798 0.8× 667 1.1× 579 0.9× 328 0.6× 487 1.1× 39 4.2k
Neil J. Perkins United States 43 866 0.8× 733 1.2× 578 0.9× 1.7k 3.0× 543 1.3× 177 7.9k
Katie Harron United Kingdom 27 1.3k 1.2× 876 1.4× 556 0.9× 980 1.7× 605 1.4× 146 5.9k

Countries citing papers authored by Jan Y. Verbakel

Since Specialization
Citations

This map shows the geographic impact of Jan Y. Verbakel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Y. Verbakel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Y. Verbakel more than expected).

Fields of papers citing papers by Jan Y. Verbakel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Y. Verbakel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Y. Verbakel. The network helps show where Jan Y. Verbakel may publish in the future.

Co-authorship network of co-authors of Jan Y. Verbakel

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Y. Verbakel. A scholar is included among the top collaborators of Jan Y. Verbakel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Y. Verbakel. Jan Y. Verbakel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saso, Srdjan, Lorraine Kasaven, Nicolas Galazis, et al.. (2024). An umbrella review of meta-analyses regarding the incidence of female-specific malignancies after fertility treatment. Fertility and Sterility. 123(3). 506–519. 2 indexed citations
2.
Llor, Carl, Andreas Plate, Lars Bjerrum, et al.. (2024). C-reactive protein point-of-care testing in primary care—broader implementation needed to combat antimicrobial resistance. Frontiers in Public Health. 12. 1397096–1397096. 3 indexed citations
3.
4.
Burghgraeve, Tine De, et al.. (2023). Cost-effectiveness of point-of-care interventions to tackle inappropriate prescribing of antibiotics in high- and middle-income countries: a systematic review. Journal of Antimicrobial Chemotherapy. 78(4). 893–912. 7 indexed citations
5.
Conrad, Nathalie, Shivani Misra, Jan Y. Verbakel, et al.. (2023). OP0007 INCIDENCE, PREVALENCE AND CO-OCCURRENCE OF AUTOIMMUNE DISORDERS, TRENDS OVER TIME AND BY AGE, SEX AND SOCIOECONOMIC STATUS. A POPULATION-BASED STUDY IN 22 MILLION INDIVIDUALS.. Annals of the Rheumatic Diseases. 82. 5–6. 3 indexed citations
6.
Deschepper, Ellen, Els Duysburgh, Tine De Burghgraeve, et al.. (2022). Prevalence of SARS-CoV-2 antibodies among Belgian nursing home residents and staff during the primary COVID-19 vaccination campaign. European Journal of General Practice. 29(2). 2149732–2149732. 6 indexed citations
7.
Adriaenssens, Niels, Béatrice Scholtes, Robin Bruyndonckx, et al.. (2022). Prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-up. BMJ Open. 12(9). e065897–e065897. 2 indexed citations
8.
Verbakel, Jan Y., et al.. (2022). Laser versus sham for genitourinary syndrome of menopause: A randomised controlled trial. BJOG An International Journal of Obstetrics & Gynaecology. 130(3). 312–319. 28 indexed citations
9.
Digregorio, Marina, Ellen Deschepper, Els Duysburgh, et al.. (2022). Vaccine Hesitancy towards the COVID-19 Vaccine in a Random National Sample of Belgian Nursing Home Staff Members. Vaccines. 10(4). 598–598. 12 indexed citations
10.
Mariën, Joachim, Christine Lammens, Margareta Ieven, et al.. (2021). Prospective SARS-CoV-2 cohort study among primary health care providers during the second COVID-19 wave in Flanders, Belgium. Family Practice. 39(1). 92–98. 8 indexed citations
11.
Eynde, Jef Van den, Michel Pompeu Sá, Dirk Vlasselaers, et al.. (2021). Strategies to Prevent Acute Kidney Injury after Pediatric Cardiac Surgery. Clinical Journal of the American Society of Nephrology. 16(10). 1480–1490. 22 indexed citations
12.
Hoof, Viviane Van, Laurent Blairon, Nathalie De Vos, et al.. (2021). Organisation and quality monitoring for point-of-care testing (POCT) in Belgium: proposal for an expansion of the legal framework for POCT into primary health care. Acta Clinica Belgica. 77(2). 329–336. 11 indexed citations
13.
Galazis, Nicolas, Benjamin P. Jones, Timothy Bracewell‐Milnes, et al.. (2021). Fertility Treatment and Cancers—The Eternal Conundrum: A Systematic Review and Meta-analysis. Obstetrical & Gynecological Survey. 76(6). 343–344. 1 indexed citations
14.
Verbakel, Jan Y., Joseph Lee, Clare Goyder, et al.. (2019). Impact of point-of-care C reactive protein in ambulatory care: a systematic review and meta-analysis. BMJ Open. 9(1). e025036–e025036. 46 indexed citations
15.
Cattani, Laura, Dominique Van Schoubroeck, Susanne Housmans, et al.. (2019). Exo-anal imaging of the anal sphincter: a comparison between introital and transperineal image acquisition. International Urogynecology Journal. 31(6). 1107–1113. 9 indexed citations
16.
Calster, Ben Van, Laure Wynants, Jan Verbeek, et al.. (2018). Reporting and Interpreting Decision Curve Analysis: A Guide for Investigators. European Urology. 74(6). 796–804. 723 indexed citations breakdown →
17.
Smeets, Miek, Joris Penders, Viviane Van Hoof, et al.. (2017). Accuracy, user-friendliness and usefulness of the Cobas h232 point-of-care test for NT-proBNP in primary care. Journal of Clinical Pathology. 71(6). 539–545. 10 indexed citations
18.
Froyman, Wouter, C. Landolfo, T. Bourne, et al.. (2016). Performance of the RMI and IOTA ADNEX and Simple Rules risk model in the evaluation of adnexal masses not classifiable using the Easy Descriptors as first step. BOA (University of Milano-Bicocca). 123(123). 83–84.
19.
Meys, Evelyne M. J., J. Kaijser, Roy F.P.M. Kruitwagen, et al.. (2016). Subjective assessment versus ultrasound models to diagnose ovarian cancer: A systematic review and meta-analysis. European Journal of Cancer. 58. 17–29. 174 indexed citations
20.
Thompson, Matthew, Ann Van den Bruel, Jan Y. Verbakel, et al.. (2012). Systematic review and validation of prediction rules for identifying children with serious infections in emergency departments and urgent-access primary care.. Health Technology Assessment. 16(15). 1–100. 260 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Varda Shalev Breakdown of academic impact, for papers by Catherine Quantin Breakdown of academic impact, for papers by Karimollah Hajian‐Tilaki Breakdown of academic impact, for papers by Kym I E Snell Breakdown of academic impact, for papers by Robert Wolff Breakdown of academic impact, for papers by Gareth Ambler Breakdown of academic impact, for papers by Laure Wynants Breakdown of academic impact, for papers by Joris A. H. de Groot Breakdown of academic impact, for papers by Neil J. Perkins Breakdown of academic impact, for papers by Katie Harron
Rankless by CCL
2026